SharonAI Holdings Inc. (SHAZ) is an Australian "neocloud" that sells cloud GPU compute capacity for artificial intelligence workloads, operating through a hybrid model of third-party data centers and its own facilities. The stock is trading at $18.67, down 7.25% from Monday's close of $20.13, putting the shares on course for another negative session in a slide that has erased roughly 77% from an August intraday peak near $80. The move was confirmed as a decline in both direction and magnitude. The immediate reason cited by markets is a third-quarter revenue shortfall and a further delay in the contracted revenue ramp, compounded by a steep target-price cut at a longtime bull and uncertainty over new U.S. export restrictions on advanced chips.
SharonAI reported third-quarter results after Monday's close. The adjusted loss of $1.14 per share was slightly better than the $1.17 deficit analysts expected, but revenue of $9.93 million landed far below consensus near $26.9 million. Revenue did grow about 414% sequentially and roughly twentyfold year over year, yet the miss lands on the metric investors are actually paying for: the pace at which signed contracts convert into billing.
Management pushed the timeline out again. Roughly 30 MW of capacity is now expected to bill from January 2027 at $400 million to $450 million of annualized run-rate revenue. Earlier in the year, the company had targeted an exit-2026 run rate above $470 million. Billing on its NVIDIA AI Compute Program capacity now ramps from July to November 2027 rather than the third quarter of 2027.
The headline contracted base still grew, with total contract value near $9.6 billion versus $8.8 billion at the second-quarter call, but that figure is net of a terminated $373 million contract dropped over customer credit concerns. Meanwhile, all-in capital spending per megawatt rose to about $50 million from roughly $39 million previously cited, lifting funding requirements for a business that reported a $43.8 million net loss and a $25.8 million adjusted EBITDA deficit for the quarter.
Cantor Fitzgerald lowered its target to $45 from $109, a cut of nearly 59%, while reiterating an Overweight rating. The analyst now values the company at 8.5x 2028 estimated EV/EBIT rather than 7x 2027 estimated EV/EBITDA, reflecting capacity formerly expected by year-end shifting into 2027 and a more conservative stance on growth. B. Riley reaffirmed a Buy rating and $78 target, attributing the revenue gap to timing as large clusters complete final testing, with customer acceptance expected in December. The dispersion between the two notes illustrates the debate: the equity is priced on execution dates that have now moved several times.
Management said the Bureau of Industry and Security's new chip-export restrictions could require exemptions for some customer contracts, without quantifying the exposure. The company said it believes exemptions should leave the business unaffected, but the disclosure adds a policy variable to a name already sensitive to anything touching AI hardware access.
The decline was idiosyncratic. NBIS rose about 1.3%, CRWV slipped less than 1% and IREN was roughly unchanged, while the Nasdaq-100 and S&P 500 traded near the flat line. Monday's volume of 2.57 million shares exceeded the roughly 2.29 million-share average, consistent with post-earnings repositioning. Technically, the stock broke below the $19 area that had held as support in early November and remains far under its 50-day and 200-day averages, a structure that has capped every rebound since September. A quarterly 13F disclosure showing Situational Awareness LP held about $440 million of SharonAI stock at September 30, some 28% of that portfolio, also drew attention to how concentrated the register is relative to daily trading.
The score runs on a 0-to-100 scale, where 0 means no meaningful news and a move that is normal for the stock, and 100 means transformative news alongside an extreme, rare price move. SharonAI lands at 39 out of 100.
The verified news was substantive: a revenue miss of more than 60% against consensus, another slip in the billing timeline, a terminated contract and a 59% target cut from a supportive analyst. That is material for a company of roughly $0.7 billion in market value. The price response, however, was unremarkable by this stock's standards. Today's 7.25% decline is only about 1.1 times its typical daily move of roughly 6.5% over the past 79 sessions, and moves of that size or larger occurred 21 times in the last 60 sessions. Strong news, ordinary volatility for this instrument, hence a middling score.
Attention now shifts to the fourth-quarter report and, more importantly, to whether the first 30 MW actually begins billing in January 2027. Investors will look for progress on the $4 billion-plus GPU facility tied to the NVIDIA contract, alongside customer acceptance milestones in December. Analyst estimates remain widely dispersed, with published targets ranging from $45 to $124, so guidance revisions are likely to move the shares more than the consensus itself. Sector developments around AI capacity pricing and export licensing are equally relevant. Key risks include further delivery slippage, dilution from a $1.0 billion convertible overhang and a share count that has grown to 38.3 million, and any customer credit deterioration of the kind that prompted the contract termination.
Tickeron runs hundreds of AI trading bots spanning thousands of tickers, but only the strongest performers under current market conditions make it into the curated Trending AI Robots section. The bots differ widely by strategy, timeframe, performance metrics and the symbols they trade, so the list offers a useful read on which automated approaches are working right now. In a tape as volatile as this one, that kind of live performance comparison is worth a look.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where SHAZ advanced for three days, in 44 of 68 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SHAZ's RSI Oscillator exited the oversold zone, 5 of 9 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 56%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 16 of 39 cases where SHAZ's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 41%.
The Moving Average Convergence Divergence (MACD) for SHAZ just turned positive on October 29, 2026. Looking at past instances where SHAZ's MACD turned positive, the stock continued to rise in 15 of 44 cases over the following month. The odds of a continued upward trend are 34%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SHAZ as a result. In 14 of 60 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 23%.
The 50-day moving average for SHAZ moved below the 200-day moving average on November 04, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SHAZ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.
The Aroon Indicator for SHAZ entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 83 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.691) is normal, around the industry mean (2.898). P/E Ratio (-1.614) is within average values for comparable stocks, (18.492). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.284). Dividend Yield (0.000) settles around the average of (0.224) among similar stocks. P/S Ratio (588.235) is also within normal values, averaging (139.965).
The Tickeron Price Growth Rating for this company is 92 (best 1 - 100 worst), indicating slightly worse than average price growth. SHAZ’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SHAZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry InformationTechnologyServices